WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr | ₹329 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
Year | Revenue |
---|---|
Mar2024 | ₹631 Cr |
Mar2023 | ₹513 Cr |
Mar2022 | ₹466 Cr |
Mar2021 | ₹428 Cr |
Mar2020 | ₹329 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹631 Cr | 22.97 | |
Mar2023 | ₹513 Cr | 10.12 | |
Mar2022 | ₹466 Cr | 8.96 | |
Mar2021 | ₹428 Cr | 30.03 | |
Mar2020 | ₹329 Cr | - |
Compare Revenue of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,735.3 Cr | -3.6% | -21.4% | 54.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,331.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,046.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,668.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹100,166.0 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,441.0 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -3.6% |
-21.4% |
54.8% |
SENSEX | -3% |
-4.8% |
-0% |
You may also like the below Video Courses